Missing: Catalytica's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Catalytica's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Catalytica News
Aug 22, 2019
COMPANY NEWS; DSM TO ACQUIRE CATALYTICA FOR $800 MILLION By Bloomberg News August 4, 2000, Section C, Page 3 Buy Reprints TimesMachine is an exclusive benefit for home delivery and digital subscribers. DSM N.V. of the Netherlands agreed yesterday to buy Catalytica Inc. for about $800 million in cash and debt to strengthen its position as the world's biggest supplier of high-profit pharmaceutical ingredients. DSM plans to keep Catalytica's drug division and spin off the combustion systems and advanced technologies units. Investors in Catalytica, based in Mountain View, Calif., will gain stock in the new business and be paid $9 to $10 a share, depending on taxes associated with the spinoff. DSM will pay about $750 million in cash and assume about $50 million in debt. Advertisement
Catalytica Frequently Asked Questions (FAQ)
Where is Catalytica's headquarters?
Catalytica's headquarters is located at 430 Ferguson Drive, Mountain View.
What is Catalytica's latest funding round?
Catalytica's latest funding round is Acq - P2P.
How much did Catalytica raise?
Catalytica raised a total of $150K.
Who are the investors of Catalytica?
Investors of Catalytica include DSM Venturing, U.S. Environmental Protection Agency and Mayfield.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.